{
    "components": [
        {
            "description": null, 
            "title": "MetaData"
        }
    ], 
    "contributors": [
        {
            "affiliation": "VA Connecticut Healthcare System", 
            "email": null, 
            "full_name": "Marc I Rosen, M.D.", 
            "role": "Principal Investigator"
        }
    ], 
    "current_status": "Withdrawn", 
    "date_processed": "June 05, 2014", 
    "description": "\n      The purpose of this study is to evaluate the effects of gamma hydroxybutyric on\n      naloxone-precipitated opiate withdrawal.\n    ", 
<<<<<<< HEAD:ct_osf_json/NCT00000193_osf.json
    "files": ["../ct_xml/NCT00000193.xml", "../ct_raw_json/NCT00000193_raw.json"],
=======
    "files": [
        "../ct_xml/NCT00000193.xml", 
        "../ct_raw_json/NCT00000193_raw.json"
    ], 
>>>>>>> a78758cf97002a4a2277f812dd682cce64bb8e1c:ct_osf_json/NCT00000193_osf.json
    "geo_data": [
        {
            "location_name": "VA Connecticut Healthcare System", 
            "location_zip": "06519"
        }
    ], 
    "id": "NCT00000193", 
    "imported_from": "clinicaltrials.gov", 
    "phase": "Phase 2", 
    "references": [], 
    "tags": [
        "clinical trial"
    ], 
    "title": "Neurobiology of Opioid Dependence: 2", 
    "url": "http://clinicaltrials.gov/show/NCT00000193"
}